Finally, we show that the urotensin receptor antagonist SB657510 can inhibit the growth and blood stream invasion of TSC2-deficient ELT3 cells in a mouse xenograft model, as well as the expression of VEGF-D, a known biomarker related to LAM. The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.